Evidence map›Paper›PMID 34645409›Full record

ArticleBMC infectious diseases2021

A transferrable IncL/M plasmid harboring a gene encoding IMP-1 metallo-β-lactamase in clinical isolates of Enterobacteriaceae.

Nobuyoshi Mori, Tatsuya Tada, Satoshi Oshiro, Kyoko Kuwahara-Arai, Teruo Kirikae, Yuki Uehara

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Analysis of the stepwise acquisition ofJAC-antimicrobial resistance · 2023
    Article
  3. Article
  4. Article
  5. Frontiers in microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Nobuyoshi MoriDepartment of Infectious Diseases, St. Luke's International Hospital, Tokyo, Japan.
Tatsuya TadaDepartment of Microbiology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan. t-tada@juntendo.ac.jp.ORCID http://orcid.org/0000-0002-3053-1879
Satoshi OshiroDepartment of Microbiology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Kyoko Kuwahara-AraiDepartment of Microbiology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Teruo KirikaeDepartment of Microbiology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Yuki UeharaDepartment of Microbiology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Juntendo University · JP

Funding

japan agency for medical research and development 21fk0108604h0701
6 · The paper itself

Abstract

backgroundThe worldwide spread of carbapenemase-producing Enterobacteriaceae (CPE) has reduced the clinical utility of carbapenems. Plasmids often play an important role in the spread of genes encoding drug-resistance factors, especially in the horizontal transfer of these genes among species of Enterobacteriaceae. This study describes a patient infected with three species of CPE carrying an identical transferrable IncL/M plasmid.

methodsClinical isolates of CPE were collected at St. Luke's International Hospital, Tokyo, Japan, from 2015 to 2019. Three species of CPE isolates, Enterobacter cloacae, Klebsiella aerogenes and Serratia marcescens, were isolated from a patient who developed severe gallstone pancreatitis associated with bloodstream infection, with all three isolates producing IMP-1 metallo-β-lactamase. The complete sequences of the plasmids of the three isolates were determined by both MiSeq and MinION. The medical chart of this patient was retrospectively reviewed conducted to obtain relevant clinical information.

resultsThe three CPE species carried an IncL/M plasmid, pSL264, which was 81,133 bp in size and harbored bla

conclusionThe IncL/M plasmid pSL264 harboring bla

Indexed as

EnterobacteriaceaeEnterobacteriaceae InfectionsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesEnterobacter cloacaeHumansMicrobial Sensitivity TestsPlasmidsRetrospective StudiesAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemase producing EnterobacteriaceaeIMP-1 metallo-β-lactamaseIncL/M

Identifiers

PMID34645409
PMCPMC8513173
OpenAlexW3206557273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.